E. Vieta a, ⁎ 
, D. Popovic a, b, A.R. Rosa a, c, B. Solé a, I. Grande a, B.N. Frey d, A. Martinez-Aran a, J. Sanchez-Moreno a, V. Balanzá-Martínez e, R. Tabarés-Seisdedos e, F. Kapczinski c
a Bipolar Disorders Program, Clinical Institute of Neuroscience, University Clinic Hospital of Barcelona, IDIBAPS, CIBERSAM, Villarroel 170, 08036 Barcelona, Spain
b Department of Psychiatry, Neurobiology, Pharmacology and Biotechnology, University of Pisa, Ospedale Santa Chiara, Via Roma 67, 56100 Pisa, Italy
c Bipolar Disorders Program and INCT for Translational Medicine, Hospital de Clínicas de Porto Alegre, UFRGS, Ramiro Barcelos, 2350 CEP 90035-003, Porto Alegre, RS, Brazil
d Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada H3A 2B4 and Montreal Neurological Institute, McGill University, Montreal, QC, Canada
e Teaching Unit of Psychiatry and Psychological Medicine, Department of Medicine, University of Valencia, CIBERSAM, Blasco-Ibáñez 17, 46010 Valencia, Spain